Prognostic significance of bone marrow biopsy in essential thrombocythemia

Claudio Annaloro, Giorgio Lambertenghi Deliliers, Alessandro Oriani, Ermanno Pozzoli, Daniela Lambertenghi Deliliers, Franca Radaelli, Paola Faccini

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Background and Objective. The diagnostic and prognostic value of bone marrow biopsy (BMB) has been widely investigated in patients with chronic myeloproliferative disorders (CMPD). The present study is based on a review of the results of routine BMBs taken from 93 essential thrombocythemia (ET) patients at the time of diagnosis. Design and Methods. The common BMB histologic parameters and clinico-hematologic variables were considered for diagnostic and prognostic purposes. Clinico-pathologic correlations were looked for univariately. Moreover, the diagnostic significance of the histologic findings was tested by means of cluster analysis. Overall survival and event-free survival were considered as prognostic endpoints. Results. There were no correlations between the clinic and pathologic findings, and none of the histologic and clinical parameters was predictive of survival or the occurrence of major clinical events. Cluster analysis of the BMB findings revealed two distinct morphologic patterns: one was clearly myeloproliferative; the other had somewhat dysplastic features. The event- free and overall survival rates in the latter group were significantly worse (p= 0.0377 and p=0.0162 respectively), with major ischemic events accounting for most of the difference in event-free survival. Interpretation and Conclusions. These results have no clearcut counterpart in the literature, but we feel that dysplastic BMB findings could be included in the definition of ET prognostic scores in order to allow therapeutic strategies to be adapted to the level of risk.

Original languageEnglish
Pages (from-to)17-21
Number of pages5
JournalHaematologica
Volume84
Issue number1
Publication statusPublished - Jan 1999

Fingerprint

Essential Thrombocythemia
Bone Marrow
Disease-Free Survival
Biopsy
Cluster Analysis
Myeloproliferative Disorders
Survival
Survival Rate

Keywords

  • Bone marrow histology
  • Essential thrombocythemia
  • Prognostic factors

ASJC Scopus subject areas

  • Hematology

Cite this

Annaloro, C., Deliliers, G. L., Oriani, A., Pozzoli, E., Deliliers, D. L., Radaelli, F., & Faccini, P. (1999). Prognostic significance of bone marrow biopsy in essential thrombocythemia. Haematologica, 84(1), 17-21.

Prognostic significance of bone marrow biopsy in essential thrombocythemia. / Annaloro, Claudio; Deliliers, Giorgio Lambertenghi; Oriani, Alessandro; Pozzoli, Ermanno; Deliliers, Daniela Lambertenghi; Radaelli, Franca; Faccini, Paola.

In: Haematologica, Vol. 84, No. 1, 01.1999, p. 17-21.

Research output: Contribution to journalArticle

Annaloro, C, Deliliers, GL, Oriani, A, Pozzoli, E, Deliliers, DL, Radaelli, F & Faccini, P 1999, 'Prognostic significance of bone marrow biopsy in essential thrombocythemia', Haematologica, vol. 84, no. 1, pp. 17-21.
Annaloro C, Deliliers GL, Oriani A, Pozzoli E, Deliliers DL, Radaelli F et al. Prognostic significance of bone marrow biopsy in essential thrombocythemia. Haematologica. 1999 Jan;84(1):17-21.
Annaloro, Claudio ; Deliliers, Giorgio Lambertenghi ; Oriani, Alessandro ; Pozzoli, Ermanno ; Deliliers, Daniela Lambertenghi ; Radaelli, Franca ; Faccini, Paola. / Prognostic significance of bone marrow biopsy in essential thrombocythemia. In: Haematologica. 1999 ; Vol. 84, No. 1. pp. 17-21.
@article{23d7c3a24c3747a99696d25e9bb15819,
title = "Prognostic significance of bone marrow biopsy in essential thrombocythemia",
abstract = "Background and Objective. The diagnostic and prognostic value of bone marrow biopsy (BMB) has been widely investigated in patients with chronic myeloproliferative disorders (CMPD). The present study is based on a review of the results of routine BMBs taken from 93 essential thrombocythemia (ET) patients at the time of diagnosis. Design and Methods. The common BMB histologic parameters and clinico-hematologic variables were considered for diagnostic and prognostic purposes. Clinico-pathologic correlations were looked for univariately. Moreover, the diagnostic significance of the histologic findings was tested by means of cluster analysis. Overall survival and event-free survival were considered as prognostic endpoints. Results. There were no correlations between the clinic and pathologic findings, and none of the histologic and clinical parameters was predictive of survival or the occurrence of major clinical events. Cluster analysis of the BMB findings revealed two distinct morphologic patterns: one was clearly myeloproliferative; the other had somewhat dysplastic features. The event- free and overall survival rates in the latter group were significantly worse (p= 0.0377 and p=0.0162 respectively), with major ischemic events accounting for most of the difference in event-free survival. Interpretation and Conclusions. These results have no clearcut counterpart in the literature, but we feel that dysplastic BMB findings could be included in the definition of ET prognostic scores in order to allow therapeutic strategies to be adapted to the level of risk.",
keywords = "Bone marrow histology, Essential thrombocythemia, Prognostic factors",
author = "Claudio Annaloro and Deliliers, {Giorgio Lambertenghi} and Alessandro Oriani and Ermanno Pozzoli and Deliliers, {Daniela Lambertenghi} and Franca Radaelli and Paola Faccini",
year = "1999",
month = "1",
language = "English",
volume = "84",
pages = "17--21",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "1",

}

TY - JOUR

T1 - Prognostic significance of bone marrow biopsy in essential thrombocythemia

AU - Annaloro, Claudio

AU - Deliliers, Giorgio Lambertenghi

AU - Oriani, Alessandro

AU - Pozzoli, Ermanno

AU - Deliliers, Daniela Lambertenghi

AU - Radaelli, Franca

AU - Faccini, Paola

PY - 1999/1

Y1 - 1999/1

N2 - Background and Objective. The diagnostic and prognostic value of bone marrow biopsy (BMB) has been widely investigated in patients with chronic myeloproliferative disorders (CMPD). The present study is based on a review of the results of routine BMBs taken from 93 essential thrombocythemia (ET) patients at the time of diagnosis. Design and Methods. The common BMB histologic parameters and clinico-hematologic variables were considered for diagnostic and prognostic purposes. Clinico-pathologic correlations were looked for univariately. Moreover, the diagnostic significance of the histologic findings was tested by means of cluster analysis. Overall survival and event-free survival were considered as prognostic endpoints. Results. There were no correlations between the clinic and pathologic findings, and none of the histologic and clinical parameters was predictive of survival or the occurrence of major clinical events. Cluster analysis of the BMB findings revealed two distinct morphologic patterns: one was clearly myeloproliferative; the other had somewhat dysplastic features. The event- free and overall survival rates in the latter group were significantly worse (p= 0.0377 and p=0.0162 respectively), with major ischemic events accounting for most of the difference in event-free survival. Interpretation and Conclusions. These results have no clearcut counterpart in the literature, but we feel that dysplastic BMB findings could be included in the definition of ET prognostic scores in order to allow therapeutic strategies to be adapted to the level of risk.

AB - Background and Objective. The diagnostic and prognostic value of bone marrow biopsy (BMB) has been widely investigated in patients with chronic myeloproliferative disorders (CMPD). The present study is based on a review of the results of routine BMBs taken from 93 essential thrombocythemia (ET) patients at the time of diagnosis. Design and Methods. The common BMB histologic parameters and clinico-hematologic variables were considered for diagnostic and prognostic purposes. Clinico-pathologic correlations were looked for univariately. Moreover, the diagnostic significance of the histologic findings was tested by means of cluster analysis. Overall survival and event-free survival were considered as prognostic endpoints. Results. There were no correlations between the clinic and pathologic findings, and none of the histologic and clinical parameters was predictive of survival or the occurrence of major clinical events. Cluster analysis of the BMB findings revealed two distinct morphologic patterns: one was clearly myeloproliferative; the other had somewhat dysplastic features. The event- free and overall survival rates in the latter group were significantly worse (p= 0.0377 and p=0.0162 respectively), with major ischemic events accounting for most of the difference in event-free survival. Interpretation and Conclusions. These results have no clearcut counterpart in the literature, but we feel that dysplastic BMB findings could be included in the definition of ET prognostic scores in order to allow therapeutic strategies to be adapted to the level of risk.

KW - Bone marrow histology

KW - Essential thrombocythemia

KW - Prognostic factors

UR - http://www.scopus.com/inward/record.url?scp=0032858781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032858781&partnerID=8YFLogxK

M3 - Article

C2 - 10091388

AN - SCOPUS:0032858781

VL - 84

SP - 17

EP - 21

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 1

ER -